3,241 followers
Persistence rate over 12 months of #teriparatide treatment was 34.9% in claims data base Japan (n=553). One-third of patients had no subsequent treatment after teriparatide. Usui T et al. Arch Osteoporos 3 May 2018 online https://t.co/YRr963a28c